Swedish Orphan Biovitrum Forecast, price target & analysts
Swedish Orphan Biovitrum Target price 2025 - Analyst rating & recommendation
Swedish Orphan Biovitrum Classifications & Recommendation:
Swedish Orphan Biovitrum Price Target
| Target Price | SEK370.31 |
| Price | SEK315.60 |
| Potential |
17.33%
register free of charge
|
| Number of Estimates | 13 |
|
13 Analysts have issued a price target Swedish Orphan Biovitrum 2026 .
The average Swedish Orphan Biovitrum target price is SEK370.31.
This is
17.33%
register free of charge
SEK405.00
28.33%
register free of charge
SEK285.00
9.70%
register free of charge
|
|
| A rating was issued by 15 analysts: 11 Analysts recommend Swedish Orphan Biovitrum to buy, 3 to hold and 1 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Swedish Orphan Biovitrum stock has an average upside potential 2026 of
17.33%
register free of charge
|
Sales and Margin forecast 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Billion SEK | 26.03 | 28.86 |
| 17.64% | 10.90% | |
| EBITDA Margin | 36.53% | 37.53% |
| 3.29% | 2.73% | |
| Net Margin | 15.00% | 17.14% |
| 29.38% | 14.24% |
13 Analysts have issued a sales forecast Swedish Orphan Biovitrum 2025 . The average Swedish Orphan Biovitrum sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Swedish Orphan Biovitrum EBITDA forecast 2025. The average Swedish Orphan Biovitrum EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
13 Swedish Orphan Biovitrum Analysts have issued a net profit forecast 2025. The average Swedish Orphan Biovitrum net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029
| Dec '24 |
2025 Estimates |
|
|---|---|---|
| Earnings Per Share SEK | 11.37 | 14.40 |
| 52.21% | 26.65% | |
| P/E | 21.62 | |
| EV/Sales | 4.25 |
13 Analysts have issued a Swedish Orphan Biovitrum forecast for earnings per share. The average Swedish Orphan Biovitrum <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Swedish Orphan Biovitrum stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Swedish Orphan Biovitrum...
Current Swedish Orphan Biovitrum Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| HSBC | Locked ➜ Locked | Locked | Nov 24 2024 |
| BERENBERG | Locked ➜ Locked | Locked | Oct 30 2024 |
| PARETO SECURITIES AS | Locked ➜ Locked | Locked | Oct 27 2024 |
| DNB MARKETS | Locked ➜ Locked | Locked | Oct 24 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
HSBC: Locked ➜ Locked
|
Nov 24 2024 |
|
Locked
BERENBERG: Locked ➜ Locked
|
Oct 30 2024 |
|
Locked
PARETO SECURITIES AS: Locked ➜ Locked
|
Oct 27 2024 |
|
Locked
DNB MARKETS: Locked ➜ Locked
|
Oct 24 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
